Provided by Tiger Trade Technology Pte. Ltd.

Aptevo Therapeutics

1.76
0.0000
Post-market: 1.75-0.0143-0.81%19:58 EDT
Volume:12.57K
Turnover:22.24K
Market Cap:3.17M
PE:-0.03
High:1.80
Open:1.80
Low:1.76
Close:1.76
52wk High:35.64
52wk Low:1.37
Shares:1.80M
Float Shares:1.70M
Volume Ratio:0.45
T/O Rate:0.74%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-58.0829
EPS(LYR):-82.2951
ROE:-420.34%
ROA:-111.49%
PB:0.52
PE(LYR):-0.02

Loading ...

Mar 27, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Mar 25, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Mar 20, 2025

Major Issues Report

Form 8-K - Current report
Mar 03, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Feb 25, 2025

Correspondence

Form CORRESP - Correspondence
Feb 14, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2025

Major Issues Report

Form 8-K - Current report
Feb 11, 2025

Major Issues Report

Form 8-K - Current report
Jan 02, 2025

Correspondence

Form CORRESP - Correspondence
Dec 12, 2024

Major Issues Report

Form 8-K - Current report
Dec 12, 2024

Major Issues Report

Form 8-K - Current report
Dec 04, 2024

Major Issues Report

Form 8-K - Current report
Dec 03, 2024

Major Issues Report

Form 8-K - Current report
Nov 26, 2024

Major Issues Report

Form 8-K - Current report
Nov 22, 2024

Major Issues Report

Form 8-K - Current report
Nov 20, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 08, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2024

Major Issues Report

Form 8-K - Current report